Yahoo Finance • 22 days ago
We recently published a list of 10 Most Promising Penny Stocks According to Hedge Funds. In this article, we are going to take a look at where Nuvation Bio Inc. (NYSE:NUVB) stands against other most promising penny stocks. Value in Small-... Full story
Yahoo Finance • 5 months ago
SAN FRANCISCO and SUZHOU, China, June 2, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatm... Full story
Yahoo Finance • 11 months ago
In this article, we will take a detailed look at the16 Best Penny Stocks To Buy For 2024. For a quick overview of such stocks, read our article 5 Best Penny Stocks To Buy For 2024. The stock market’s optimism wave recently saw a break aft... Full story
Yahoo Finance • 12 months ago
NEW YORK, November 13, 2023--(BUSINESS WIRE)--Nuvation Bio Inc. (NYSE: NUVB) (the "Company") announced today that Jennifer Fox will be stepping down from her role as Chief Financial Officer to pursue a new opportunity. Ms. Fox has advised... Full story
Yahoo Finance • 2 years ago
In this piece, we will take a look at the 12 best biotechnology stocks to buy under $20. For more stocks, head on over to 5 Best Biotech Stocks To Buy Under $20. The biotechnology industry is one of the hottest sectors right now, particul... Full story
Yahoo Finance • 2 years ago
Maraganore brings more than 35 years of scientific, research and development, capital markets and managerial leadership expertise to ProKidney Fox joins Board with more than 25 years of healthcare investment banking, finance and capital m... Full story
Yahoo Finance • 2 years ago
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, July 05, 2022 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Nuvation Bio Inc. (“Nuvation” or “the Company”) (NYSE: NUVB) investor... Full story
Yahoo Finance • 2 years ago
NEW YORK, June 27, 2022--(BUSINESS WIRE)--Nuvation Bio Inc. (NYSE: NUVB), a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates, today announced the... Full story